{
  "url": "https://www.law.cornell.edu/regulations/new-york/10-NYCRR-80.3",
  "title": "N.Y. Comp. Codes R. & Regs. Tit. 10 ยง 80.3 - Exceptions, reclassification and exemptions of scheduled controlled substances",
  "content": "N.Y. Comp. Codes R. & Regs. Tit. 10 ยง 80.3 - Exceptions, reclassification and exemptions of scheduled controlled substances\n\nState Regulations\n(a) Exceptions. (1)\n\nThose nonnarcotic substances listed in section\n1308.22\nof title 21 of the Code of Federal Regulations, currently and as thereinafter amended, are excepted from the application of sections\n3306\nand\n3319\nof the Public Health Law. (2)\n\nThose drugs, which are restricted by law to dispensing on prescription, listed in section\n1308.32\nof title 21 of the Code of Federal Regulations, currently and as thereinafter amended, are excepted from the application of sections\n3306\nand\n3319\nof the Public Health Law. (3)\n\nThose chemical preparations and mixtures listed in section\n1308.24\nof title 21 of the Code of Federal Regulations, currently and as thereinafter amended, are excepted from the application of sections\n3306\nand\n3319\nof the Public Health Law. (4)\n\nThe following compounds, mixtures or preparations containing a narcotic antagonist substance having no potential for abuse, and being excepted or exempted from control under the Federal Controlled Substances Act (21 USC\n801\net seq.) are excepted from the application of sections 3306 and 3319 of the Public Health Law: (i) naloxone and its salts; and\n(ii)\nnaltrexone and its salts. (b) Reclassifications. The following drugs listed in schedule II(c) of section\n3306\nof the Public Health Law are hereby reclassified as schedule III substances. TRADE NAME OR OTHER DESIGNATION\nCOMPOSITION\nMANUFACTURER OR SUPPLIER\nMediatric-tablets, capsules and liquid\n\nTablet and: Conjugated estrogens-equine (Premarin (R)), 0.25 mg.; Methyltestosterone, 2.5mg.; Ascorbic Acid (Vit. C), 100 mg. (for capsules, provided as ascorbic acid, 70 mg. and as Sodium ascorbate, 30 mg.); Cyanocobalamin, 2.5 mcg.; Thiamine mononitrate, 10.0 mg.; Riboflavin, 5.0 mg.; Niacinamide, 50.0 mg.; Pyridoxine HCl, 3.0 mg.; Calc. panto thenate, 20.0 mg.; Ferrous sulfate exsic., 30.0 mg.; Methamphetamine HCl, 1.0 mg. Liquid: (Premarin (R)) Conjugated estrogens, (U.S.P.), 0.25 mg.; Methyltestosterone, 2.5 mg.; Thiamine HCl, 5.0 mg.; Cyanocobalamin, 1.5 mcg.; Methamphetamine HCl, 1.0 mg.; Alcohol, 15%. Ayerst\n\nPhelantin--Kapseals\n\nPhenobarbital (1/2 gr) 30 mg.; Dilantin (Diphenyl- hydantoin) (11/2 gr) 100 mg.; Methamphetamine Hydrochloride 2.5 mg. Parke-Davis\n(c) Exemptions. The following compounds, mixtures or preparations containing an anabolic steroid listed in subdivision (h) of schedule II of section\n3306\nof the Public Health Law have ingredients included therein in such combinations, quantity, proportion or concentration as to reduce substantially the potential for abuse and, therefore, are exempted from the requirements of Public Health Law, article 33: Trade Name\n\nComposition\n\nManufacturer or supplier\n\nEstratest\n\nEsterified estrogens (1.25 mg); Methyl- testosterone (2.5 mg)\n\nSolvay Pharmaceuticals Marietta, GA\nEstratest HS\nEsterified estrogens (0.625 mg); Methyl-testosterone (1.25 mg)\n\nSolvay Pharmaceuticals Marietta, GA\nPremarin with Methyltestosterone\n\nConjugated estrogens (0.625 mg); Methyltestosterone (5.0 mg)\n\nWyeth-Ayerst Laboratories Philadelphia, PA\nPremarin with Methyltestosterone\n\nConjugated estrogens (1.25 mg); Methyltestosterone (10 mg)\n\nWyeth-Ayerst Laboratories Philadelphia, PA\nNotes\nN.Y. Comp. Codes R. & Regs. Tit. 10\nยง\n80.3\n\nAmended\n\nNew\n\nYork State Register May 22, 2019/Volume XLI, Issue 21, eff. 5/22/2019\n\nAmended\n\nNew\n\nYork State Register November 25, 2020/Volume XLII, Issue 47, eff. 11/25/2020\n\nState regulations are updated quarterly; we currently have two versions available. Below is a\ncomparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare. No prior version found.",
  "url_type": "regulation",
  "source_index": 2254
}